论文部分内容阅读
美国ＦＤＡ通过了法玛西亚公司生产的每天只需服用一次托特罗定 (ｔｏｌｔｅｒｏｄｉｎｅ ,Ｄｅｔｒｏｌ/Ｄｅｔｒｕｓｉｔｏｌ)治疗小便失禁。这是继 2 0 0 0年 12月在瑞士以商品名为ＤｅｔｒｕｓｉｔｏｌＳＲ经过审批后 ,第二次获得认可。以酒石酸盐缓释托特罗定胶囊的新配方
The FDA passed the French company Amatima’s treatment of urinary incontinence with tolterodine (Detrol / Detrusitol). This is the second time since its approval in December 2000 in Switzerland under the trade name Detrusitol SR. New formulation of tartrate releasing tartrate capsule with tartrate